EPISODE · Jun 21, 2026 · 7 MIN

CATT Study - DMAE

from The Fellowship Survival Kit · host Dr. Marco Víquez

En este episodio de “The Fellowship Survival Kit”, el Dr. Marco Víquez analiza a fondo el emblemático estudio CATT de 2011, un pilar fundamental en el tratamiento de la degeneración macular asociada a la edad (DMAE) neovascular. Se explora el contexto histórico que llevó a la comparación entre el Ranibizumab (aprobado por la FDA) y el Bevacizumab (usado off-label), detallando una metodología de no inferioridad que incluyó a más de 1,200 pacientes.

Episode metadata supplied by the publisher feed · Published Jun 21, 2026

Embed this episode

Attribution link and audio player

Ready to play

CATT Study - DMAE

0:00 7:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Fellowship Survival Kit?

This episode is 7 minutes long.

When was this The Fellowship Survival Kit episode published?

This episode was published on June 21, 2026.

Can I download this The Fellowship Survival Kit episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!